Highlights

02-12 Carl Zeiss Meditec: Weak start to FY2025-26, tough times ahead Alphavalue
02-12 Earnings or Else Zonebourse
02-12 Carl Zeiss Meditec Shifts Production to China – Job Cuts on the Horizon? DP
02-12 Results that leave no room for error Zonebourse
02-12 Carl Zeiss Meditec Q1 revenue EUR 467 million versus Ibes estimate EUR 484.2 million RE
02-12 Carl Zeiss Meditec AG Announces Temporarily Suspension of Earnings Guidance for the Year 2025/26 CI
02-12 Carl Zeiss Meditec Releases Details on Quarterly Figures - Forecast in the Spotlight DP
02-11 Carl Zeiss Meditec AG Reports Earnings Results for the First Quarter Ended December 31, 2025 CI
02-02 Zeiss announces NMPA approval in China for powerful ophthalmic microscopes enhancing surgical visualization RE
02-02 Zeiss Medical Technology Announces NMPA Approval in China for Powerful Ophthalmic Microscopes Enhancing Surgical Visualization CI
01-22 Weak Quarter: Carl Zeiss Meditec Withdraws Annual Target DP
01-22 JPMorgan Maintains 'Underweight' Rating on Carl Zeiss Meditec DP
01-22 Carl Zeiss Meditec Shares Plunge Following Fiscal Year Outlook DP
01-22 Carl Zeiss Meditec: Annual Target Likely Out of Reach After Weak Quarter DP
01-22 Carl Zeiss Meditec says FY 2025/26 guidance will likely not be achieved RE
01-22 Carl Zeiss Meditec Ag Revises Earnings Guidance for the Fiscal Year 2025/26 CI
12-18 Zeiss Braces for Challenging Times Ahead DP
12-11 Carl Zeiss Meditec AG Reports Earnings Results for the Full Year Ended September 30, 2025 CI
12-11 Carl Zeiss Meditec AG announces Annual dividend, payable on March 31, 2026 CI
12-11 Carl Zeiss Meditec fails to bottom out – lowest since 2017 DP
12-11 Carl Zeiss Meditec meets guidance, eyes diversification Alphavalue
12-11 Carl Zeiss Meditec Posts Growth, but Challenges Persist in China DP
12-11 Carl Zeiss Meditec FY revenue EUR 2,228 mln RE
12-11 Carl Zeiss Meditec AG Provides Earnings Outlook for Fiscal Year 2025-2026 CI
12-07 Earnings calendar for week of December 8-12, 2025: Oracle, Adobe, Broadcom a trio to watch Zonebourse
No results for this search